COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 2606: Articles 26051-26060  | Next

Novel ACE2-IgG1 fusions with increased activity against SARS-CoV-2
Iwanaga, N., Cooper, L., Rong, L., Beddingfield, B., Crabtree, J., Tripp, R. A., Kolls, J.
10.1101/2020.06.15.152157 — Posted: 2020-06-15 Discussion: Onsite
Increased plasma heparanase activity in COVID-19 patients
Buijsers, B., Yanginlar, C., Grondman, I., de Nooijer, A., Maciej-Hulme, M. L., Jonkman, I., Janssen, N., Rother, N., de Graaf, M., Pickkers, P., Kox, M., Joosten, L., Nijenhuis, T., Netea, M. G., Hillbrands, L., van de Veerdonk, F., Duivenvoorden, R., de Mast, Q., van der Vlag, J.
10.1101/2020.06.12.20129304 — Posted: 2020-06-15
A discrete-time-evolution model to forecast progress of Covid-19 outbreak
Curado, E. M. F., Curado, M. R.
10.1101/2020.06.12.20129981 — Posted: 2020-06-15
Self-reported taste and smell disorders in patients with COVID-19: distinct features in China
Song, J., Deng, Y.-K., Wang, H., Wang, Z.-C., Liao, B., Ma, J., He, C., Pan, L., Liu, Y., Alobid, I., Wang, D.-Y., Zeng, M., Mullol, J., Liu, Z.
10.1101/2020.06.12.20128298 — Posted: 2020-06-15
Dynamics of the ACE2 - SARS-CoV/SARS-CoV-2 spike protein interface reveal unique mechanisms
Ali, A., Vijayan, R.
10.1101/2020.06.10.143990 — Posted: 2020-06-14
Genotypic and antigenic study of SARS-CoV-2 from an Indian isolate.
Dhar, R., Sinha, A. Y., Seethy, A. A., Matta, S. A., Pethusamy, K., Srivastava, T., Singh, S., Mukherjee, I., Sarkar, S., Minocha, R., Purkayastha, K., Sharma, J. B., Paine, S., Karmakar, S.
10.1101/2020.06.10.140657 — Posted: 2020-06-14
In silico multi-epitope vaccine against covid19 showing effective interaction with HLA-B*15:03
Faiza, M., Abdullah, T., Calderon-Tantalean, J. F., Upadhyay, M. R., Abdelmoneim, A. H., Akram, F., Thakur, B. S., Abdulaziz, I., Ononamadu, C. J., Ghoraba, D. A., Munawar, S., Faruque, M. F. I., Kigen, C., Sharma, A., Kumar, A., Khalid, A., Gharip, A., Gupta, A., Manikumar, M., Chaudhary, U.
10.1101/2020.06.10.143545 — Posted: 2020-06-14 Discussion: Onsite
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2
Zimniak, M., Kirschner, L., Hilpert, H., Seibel, J., Bodem, J.
10.1101/2020.06.14.150490 — Posted: 2020-06-14 Discussion: Onsite
Calreticulin co-expression supports high level production of a recombinant SARS-CoV-2 spike mimetic in Nicotiana benthamiana
Margolin, E. A., Verbeek, M., Meyers, A., Chapman, R., Williamson, A.-L., Rybicki, E.
10.1101/2020.06.14.150458 — Posted: 2020-06-14 Discussion: Onsite
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
Wang, P., Liu, L., Nair, M. S., Yin, M. T., Luo, Y., Wang, Q., Yuan, T., Mori, K., Solis, A. G., Yamashita, M., Purpura, L. J., Laracy, J. C., Yu, J., Sodroski, J., Huang, Y., Ho, D. D.
10.1101/2020.06.13.150250 — Posted: 2020-06-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).